Results 51 to 60 of about 3,493 (205)

Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.

PLoS Medicine, 2021
BackgroundInfluenza is a cause of febrile acute respiratory infection (FARI) in India; however, few influenza vaccine trials have been conducted in India.
Anand Krishnan, Lalit Dar, Siddhartha Saha, Venkatesh Vinayak Narayan, Rakesh Kumar, Ramesh Kumar, Ritvik Amarchand, Shivram Dhakad, Reshmi Chokker, Avinash Choudekar, Giridara Gopal, Aashish Choudhary, Varsha Potdar, Mandeep Chadha, Kathryn E Lafond, Stephen Lindstrom, Marc-Alain Widdowson, Seema Jain   +17 more
doaj   +1 more source

Immunopotentiation by Natural Extracts: Mechanisms and Applications in Influenza Vaccine Adjuvant Development

Food Science &Nutrition, Volume 14, Issue 5, May 2026.
Natural Extracts as Candidate Influenza Vaccine Adjuvants. Seasonal influenza vaccines face limitations due to viral mutations and low efficacy in vulnerable populations. Traditional adjuvants often have safety or immune‐activation constraints, leading to increased interest in natural extracts from plants, marine organisms, and fungi.
Thi Len Ho, Eun‐Ju Ko
wiley   +1 more source

Frequency of circulating influenza-specific ASC after LAIV or TIV vaccination.

, 2013
Influenza-specific IgA ASC and IgG ASC were measured with a direct ELISPOT assay at days 7–9 after LAIV ('05-LAIV) or TIV ('05-TIV) vaccination. A: Influenza-specific IgA and IgG ASC in all subjects after administration of '05-LAIV or '05-TIV.
Tyson H. Holmes (95098), Cornelia L. Dekker (95099), Xiao-Song He (95097), George W. Kemble (95100), Harry B. Greenberg (95102), Ann. M. Arvin (95101), Sanae Sasaki (95096)   +6 more
core   +1 more source

Meeting Report: Fourth Correlates of Protection for Next Generation Influenza Vaccines

Influenza and Other Respiratory Viruses, Volume 20, Issue 4, April 2026.
ABSTRACT Background This report summarizes the discussions and conclusions from the fourth “Correlates of Protection for Next Generation Influenza Vaccines” meeting, which took place in Vienna, Austria, from October 15, 2025, to October 17, 2025. Conclusion Discussions on influenza virus correlates of protection built on prior meetings, with particular
Alina Tscherne, Rebecca Jane Cox, Florian Krammer, Anders Bonnevie   +3 more
wiley   +1 more source

The percentage of circulating influenza-specific memory B cells before and after LAIV or TIV vaccination.

, 2013
Percentages of influenza-specific memory IgG B-cells and IgA B-cells before (day 0) and 30 day (21–35 days in 2005 study, 27–47 days in 2004 study) after LAIV or TIV vaccination were measured.
Tyson H. Holmes (95098), Cornelia L. Dekker (95099), Xiao-Song He (95097), George W. Kemble (95100), Harry B. Greenberg (95102), Ann. M. Arvin (95101), Sanae Sasaki (95096)   +6 more
core   +1 more source

Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine

Viruses, 2018
Live attenuated influenza vaccines (LAIV) have prevented morbidity and mortality associated with influenza viral infections for many years and represent the best therapeutic option to protect against influenza viral infections in humans.
Luis Martínez-Sobrido, Olve Peersen, Aitor Nogales   +2 more
doaj   +1 more source

Genome‐Wide Codon Reprogramming Enables a Multifactorially Attenuated Influenza Vaccine with Broad Cross‐Protection

Advanced Science, Volume 13, Issue 9, 13 February 2026.
Genome‐wide codon reprogramming of influenza A virus introduces 1956 synonymous mutations across five segments and elevates CpG content, causing defective NA packaging, loss of NS1 accumulation, and enhanced ZAP‐mediated antiviral responses without affecting RNA or protein synthesis. These mechanisms result in profound attenuation and potent homologous
Yang Wang, Tianxin Ma, Yujiao He, Qinming Li, Kailin Mai, Minying Mo, Chenyang Cao, Jiahui Li, Pei Feng, Jiaojiao Peng, Jing Sun, Weiqi Pan, Zifeng Yang, Ling Chen   +13 more
wiley   +1 more source

Fakta, fiksjon og læring - Levende rollespill (LAIV) i historieundervisning [PDF]

Norsk pedagogisk tidsskrift, 2016
Dagens barn og unge tar interaktivitet som en selvfølge. I sin omgang med dataspill, videospill og sosiale medier er barn og unges livsverden preget av aktiv deltaking. Til tross for dette er det en internasjonal tendens i skolen til mer «chalk and talk», «skill and drill» (Roberts 2009).
openaire   +2 more sources

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector

Vaccines, 2022
The COVID-19 pandemic emerged in 2020 and has caused an unprecedented burden to all countries in the world. SARS-CoV-2 continues to circulate and antigenically evolve, enabling multiple reinfections.
Irina Isakova-Sivak, Ekaterina Stepanova, Victoria Matyushenko, Sergei Niskanen, Daria Mezhenskaya, Ekaterina Bazhenova, Elena Krutikova, Tatiana Kotomina, Polina Prokopenko, Bogdan Neterebskii, Aleksandr Doronin, Elena Vinogradova, Kirill Yakovlev, Konstantin Sivak, Larisa Rudenko   +14 more
doaj   +1 more source

Immune and Immune‐Integrated Organoids as NextGeneration Platforms for Disease Modeling

MedComm, Volume 6, Issue 12, December 2025.
This graphical abstract outlines the sources and methods for integrating immune cells into organoids. Immune cells can be derived from peripheral blood, tissues, or differentiated from human‐induced pluripotent stem cells. The immune cells are incorporated into the organoid by using coculture techniques, direct injection, as well as scaffolds and air ...
Kimiya Rashidan, Malaksima Ayadilord, Ali Hazrati, Amirhossein Nazerian, Abbas Shafiee, Seyed Mahmoud Hashemi   +5 more
wiley   +1 more source